Key Record Dates Identifier: NCT02194166
Brief Title: A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration (ESCAPE)

First Submitted : July 8, 2014
First Submitted that Met QC Criteria : July 16, 2014
First Posted : July 18, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : June 6, 2019
Last Update Posted : June 10, 2019